CD274 and hepatocellular carcinoma: Nonetheless, it is important to conduct retrograde analysis of human clinical data and determine whether HCC patients who received losartan or other AngIIR1 inhibitors exhibit an improved ORR when subjected to PD-(L)1 blockade.